AR
Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ·Healthcare·Biotechnology
$4.15
+0.12%
Mkt Cap $206.32M
Analyst Ratings
Buy
2
Hold
3
Sell
0
Price Target (6 analysts)
$14.33
Range $4.00 – $35.00
Implied Upside
+245.3%
Consensus $14.33 vs current $4.15
NASDAQ·Healthcare·Biotechnology
$4.15
+0.12%
Mkt Cap $206.32M
Buy
2
Hold
3
Sell
0
Price Target (6 analysts)
$14.33
Range $4.00 – $35.00
+245.3%
Consensus $14.33 vs current $4.15